Therapix Biosciences (Israel) Financial Indicators Patterns

TRPX -- Israel Stock  

null 33.70  0.70  2.12%

Use fundamental data analysis to confirm all available indicators of Therapix Biosciences to find out if markets are presently mispricing the corporation. We found sixteen available drivers for Therapix Biosciences Ltd which can be compared to its competition. Use Therapix Biosciences Net Income, Book Value Per Share, Beta, as well as the relationship between Cash per Share and Earnings Per Share to make sure your decision on pricing Therapix Biosciences is adequate. Use Therapix Biosciences to enhance returns of your portfolios. The stock experiences unexpected upward trend. Watch out for market signals. Check odds of Therapix Biosciences to be traded at 40.44 in 30 days

Therapix Biosciences Company Summary

Therapix Biosciences competes with Israel Chemicals, and NICE Ltd. Therapix Biosciences Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. Therapix Biosciences Ltd. was founded in 2004 and is headquartered in Givatayim, Israel. Therapix Biosciences operates under Biotechnology classification in Israel and traded on Tel Aviv Stock Exchange. It employs 9 people.

Therapix Biosciences Market Capitalization vs Earnings Per Share

Therapix Biosciences Ltd is rated third in market capitalization category among related companies. It is rated third in earnings per share category among related companies .

Therapix Biosciences Market Fundamentals

 Quote33.70
 Change(%) 2.12%
 Change0.70 
 Open33.0
 Low33.0
 High34.4
 Volume1.000
 ExchangeTLV

Distress Rating

Therapix Biosciences Financial Distress Probability

73% 
Chance of Financial Distress
Therapix Biosciences Ltd has more than 73 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info

Compare Therapix Biosciences

Compare Therapix Biosciences To Peers

Therapix Biosciences Opportunity Range

October 22, 2018 Opportunity Range

Also please take a look at World Market Map. Please also try Premium Stories module to follow macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Search macroaxis.com